Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler: A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2012
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 02 Feb 2012 Actual patient number (17) added as reported by ClinicalTrials.gov.
- 02 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.